Indoleamine 2,3-dioxygenase (IDO) is Expressed at Feto-placental Unit Throughout Mouse Gestation: An Immunohistochemical Study
Overview
Authors
Affiliations
Introduction: The cells expressing Indoleamine 2, 3-dioxygenase (IDO) in feto-maternal interface mediate tryptophan catabolism, hence protect allogeneic fetus from lethal rejection by maternal immune responses. In this study, we report immuno-localization of IDO(+) cells in murine reproductive tract and placenta throughout mouse pregnancy by immunohistochemistry.
Materials And Methods: Syngeneic pregnant mice were examined for vaginal plug to discover about their state of pregnancy. A total of three pregnant mice were examined at each stage.The examination was further confirmed by the detection of sperm in vaginal smear. On the gestational days of 2(nd), 12(th) and 18(th), the uterus and oviduct were removed and expression of IDO was investigated in the endometrium, placenta and oviduct by immunohistochemistry.
Results: Our results showed that IDO is expressed consistently in feto-maternal interface throughout pregnancy. In endometrium, expression of IDO was predominantly confined to luminal and glandular epithelial cells. Cells at junctional and labyrinth zones of placenta showed strong IDO immunoreactivity as well.
Conclusion: Expression of IDO at the protein level in reproductive tract of pregnant mice during entire periods of gestation points to its potential protective role in maintenance of pregnancy. In our knowledge this is the first report of expression of IDO in feto-maternal phase during murine pregnancy.
Does the kynurenine pathway play a pathogenic role in autism spectrum disorder?.
Santana-Coelho D Brain Behav Immun Health. 2024; 40:100839.
PMID: 39263315 PMC: 11387593. DOI: 10.1016/j.bbih.2024.100839.
Placenta: an old organ with new functions.
Khorami-Sarvestani S, Vanaki N, Shojaeian S, Zarnani K, Stensballe A, Jeddi-Tehrani M Front Immunol. 2024; 15:1385762.
PMID: 38707901 PMC: 11066266. DOI: 10.3389/fimmu.2024.1385762.
Dupont V, Berg A, Yamashita M, Huang C, Covarrubias A, Ali S J Clin Invest. 2022; 132(20).
PMID: 35943814 PMC: 9566901. DOI: 10.1172/JCI158346.
Hoffmann D, Dvorakova T, Schramme F, Stroobant V, Van den Eynde B Front Immunol. 2020; 11:601759.
PMID: 33363543 PMC: 7752949. DOI: 10.3389/fimmu.2020.601759.
Ahlstedt J, Konradsson E, Ceberg C, Nittby Redebrandt H PLoS One. 2020; 15(5):e0233617.
PMID: 32469935 PMC: 7259656. DOI: 10.1371/journal.pone.0233617.